Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:CDW
NasdaqGS:CDWElectronic

Is It Time To Revisit CDW (CDW) After A 35% One Year Share Price Slide

If you are wondering whether CDW's share price reflects its underlying value right now, you are not alone. This article walks through the numbers so you can judge that for yourself. CDW shares last closed at US$126.39, with returns of 0.3% over 7 days, a 7.2% decline over 30 days, a 5.1% decline year to date, and a 35.6% decline over 1 year, as well as a 34.7% decline over 3 years and an 11.1% decline over 5 years. Recent news around CDW has focused on its role as a major IT solutions...
ASX:29M
ASX:29MMetals and Mining

A Look At 29Metals (ASX:29M) Valuation After Its Large Follow On Equity Offer And Rights Issue

Why 29Metals is back on investor radars 29Metals (ASX:29M) has drawn fresh attention after lodging a sizeable follow on equity offering of about A$149.8m, paired with a rights issue and an associated ex dividend date on January 21, 2026. The offer covers more than 374 million ordinary shares at A$0.40, issued at a A$0.022 discount per share, raising questions for existing and prospective shareholders about dilution, capital structure, and potential valuation resets. See our latest analysis...
TSXV:VCU
TSXV:VCUMetals and Mining

Vizsla Copper (TSXV:VCU) Is Up 28.6% After Alaska Backs Palmer As Critical Minerals Hub

Vizsla Copper recently outlined its 2026 field season plans for the Palmer Project in Alaska, including up to 10,000 metres of diamond drilling, a full geological model rebuild, and technical work to formally incorporate barite and other critical minerals into future resource assessments. A formal letter of support from the Governor of Alaska, recognizing Palmer as important for U.S. critical mineral supply, underscores the project’s growing relevance as a multi-mineral asset that includes...
TSX:ITH
TSX:ITHMetals and Mining

Assessing International Tower Hill Mines (TSX:ITH) Valuation After Upsized Financing For Livengood Gold Project

International Tower Hill Mines (TSX:ITH) has just closed an upsized public offering alongside private placements, raising roughly US$115 million to fund its Livengood Gold Project in Alaska, with Paulson & Co. increasing its ownership. See our latest analysis for International Tower Hill Mines. The financing news comes after a sharp re‑rating in International Tower Hill Mines, with a 39.53% 1 month share price return and a very large 1 year total shareholder return. However, the 13.27% 1 day...
BME:CABK
BME:CABKBanks

Why CaixaBank (BME:CABK) Is Up 6.1% After Net Income Rose Despite Lower Interest Margin

CaixaBank, S.A. has released its full-year 2025 results, reporting net interest income of €10,732 million versus €11,208 million a year earlier, while net income edged up to €5,891 million from €5,787 million. This combination of lower net interest income but higher net income highlights how CaixaBank’s business mix and cost factors influenced overall profitability in 2025. We’ll now examine how CaixaBank’s higher net income despite lower net interest income shapes the company’s investment...
SEHK:2442
SEHK:2442Construction

A Look At Easy Smart Group Holdings (SEHK:2442) Valuation After Broad Board And Management Refresh

Easy Smart Group Holdings (SEHK:2442) has announced a broad refresh of its board and senior management, with two independent non executive directors and the company secretary stepping down and several new appointments taking effect on 21 January 2026. See our latest analysis for Easy Smart Group Holdings. Those board and management changes land after an exceptionally strong period for investors, with a 90 day share price return of 562.07% and a 1 year total shareholder return that is very...
NasdaqGS:ALMS
NasdaqGS:ALMSPharmaceuticals

Did Envudeucitinib’s Phase III Win Just Shift Alumis' (ALMS) Investment Narrative?

Earlier in January, Alumis reported that its lead autoimmune drug candidate, the TYK2 inhibitor envudeucitinib, met all primary and secondary endpoints with strong statistical significance in two Phase III trials for moderate-to-severe plaque psoriasis. This clinical milestone has prompted several Wall Street firms to initiate or upgrade coverage, framing envudeucitinib as a central asset in Alumis’s late-stage autoimmune pipeline. We’ll now examine how envudeucitinib’s Phase III success...
NYSE:EQR
NYSE:EQRResidential REITs

Is Equity Residential (EQR) Offering Value After A 8% One Year Share Price Decline

If you are wondering whether Equity Residential is offering fair value at around US$62.32 per share, you are not alone. This article is built to help you size up the price tag with a clear valuation lens. The stock has had a mixed run, with a 0.4% gain over the last week, a 1.1% decline over the last month, a 0.5% gain year to date, and an 8.0% decline over the past year, while the 3 year and 5 year returns sit at 9.0% and 16.0% respectively. Recent coverage has continued to focus on Equity...
ENXTPA:AF
ENXTPA:AFAirlines

Is Air France KLM (ENXTPA:AF) Still Attractive After Recent Share Price Volatility?

If you are wondering whether Air France KLM at €10.81 is genuinely good value or just looks cheap on the surface, you are in the right place. The share price is up 1.2% over the last week and 35.1% over the last year, even though it shows a 6.5% decline over 30 days and an 11.9% decline year to date. This can change how investors think about both upside and risk. That mix of recent gains and setbacks comes on the back of ongoing market attention on major European airlines, including Air...
NYSE:JHG
NYSE:JHGCapital Markets

Janus Henderson Group (JHG) Net Margin Expansion Reinforces Bullish Earnings Narrative

Janus Henderson Group (NYSE:JHG) has just posted its FY 2025 third quarter numbers, with revenue of US$700.4 million and basic EPS of US$0.92. This is set against trailing 12 month revenue of US$2.66 billion and EPS of US$3.41 that also reflect a 31.2% year over year earnings increase and a net profit margin of 19.6% versus 17.1% in the prior year. Over recent quarters, revenue has ranged from US$588.4 million in Q2 2024 to US$708.3 million in Q4 2024, while basic EPS has moved between...
NYSE:MUX
NYSE:MUXMetals and Mining

McEwen Expands Nevada Gold Bar Hub With Golden Lake Acquisition

McEwen (NYSE:MUX) has entered into a definitive agreement to acquire Golden Lake Exploration. The deal adds Golden Lake's projects adjacent to McEwen's Gold Bar Mine Complex in the Eureka Mining District in Nevada. The transaction is intended to consolidate McEwen's position around its existing operations at the Gold Bar Mine. For you as an investor, this move comes after a sharp share price run, with McEwen at $24.15 and up 193.1% over the past year and 286.4% over 3 years. The stock is...
CPSE:VWS
CPSE:VWSElectrical

Is Vestas (CPSE:VWS) Using Low‑Emissions Steel To Quietly Redraw Its Competitive Moat?

Vattenfall has ordered Vestas turbines featuring low-emissions steel for the 63 MW Clashindarroch II wind farm in Scotland, marking the first time this lower-impact material has been used in a commercial wind project. This step highlights how Vestas is integrating cleaner materials into turbine manufacturing, potentially reshaping sustainability standards across the wind supply chain. We’ll now explore how this pioneering use of low-emissions steel could influence Vestas’ investment...
NasdaqGS:SDGR
NasdaqGS:SDGRHealthcare Services

Assessing Schrödinger (SDGR) Valuation As Its Computational Platform And Novartis Collaboration Draw Fresh Attention

Schrödinger (SDGR) is back in focus as its physics based computational platform, high profile collaborations including Novartis Pharma AG, and favorable analyst endorsements draw fresh attention from investors following recent coverage. See our latest analysis for Schrödinger. Despite the recent attention around its platform and collaborations, Schrödinger’s share price has come under pressure, with a 7 day share price return of 14.92% and a 30 day share price return of 21.87%, contributing...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Regeneron Pharmaceuticals (REGN) Margin Slippage Tests Bullish Earnings Growth Narrative

Regeneron Pharmaceuticals (REGN) has put up another busy quarter, with Q3 FY 2025 revenue of US$3.8b and basic EPS of US$14.09 alongside net income of US$1,460m, all against a backdrop where trailing 12 month EPS sits at US$43.30 on revenue of US$14.2b. The company has seen revenue move from US$3.5b in Q2 FY 2024 to US$3.8b in Q3 FY 2025, while quarterly EPS has shifted from US$13.25 to US$14.09 over the same span. This gives investors a clear look at how top line and per share earnings have...
NasdaqGS:CRAI
NasdaqGS:CRAIProfessional Services

Can CRA International (CRAI) Turn an Earnings Beat and DOJ Hire into Lasting Antitrust Advantage?

Earlier this week, CRA International reported quarterly results showing 10.8% year-on-year revenue growth and earnings and revenue above analyst estimates, and also announced that antitrust economist Margaret (Peggy) Loudermilk has joined as a Vice President in its Antitrust & Competition Economics Practice. The combination of stronger-than-expected financial performance and the addition of a veteran U.S. Department of Justice antitrust leader materially reinforces CRA’s profile in complex...